BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6632921)

  • 1. Basic aggregation properties of washed rat platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation.
    Tomita T; Umegaki K; Hayashi E
    J Pharmacol Methods; 1983 Aug; 10(1):31-44. PubMed ID: 6632921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide breakdown as an indirect link between stimulation and aggregation of rat platelets by thrombin and collagen.
    Kito M; Narita H; Ishinaga M; Park HJ; Takamura H
    J Biochem; 1985 Mar; 97(3):765-72. PubMed ID: 2991207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD; Seuter F
    Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired function of TXA2 and/or calcium in the platelets from SHRSP at hypertensive ages.
    Tomita T; Umegaki K; Nakamura K; Hayashi E
    Thromb Res; 1984 Jul; 35(2):219-30. PubMed ID: 6474418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
    Brammer JP; Kerecsen L; Maguire MH
    Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin E on acute iron load-potentiated aggregation, secretion, calcium uptake and thromboxane biosynthesis in rat platelets.
    Polette A; Blache D
    Atherosclerosis; 1992 Oct; 96(2-3):171-9. PubMed ID: 1466649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.
    Teng CM; Jy W; Ouyang C
    Toxicon; 1984; 22(3):463-70. PubMed ID: 6474495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of citrate on platelet aggregation and malondialdehyde production.
    Huijgens PC; van den Berg CA; Voetdijk AM; Imandt LM
    Scand J Haematol; 1983 Aug; 31(2):129-32. PubMed ID: 6412352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
    Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
    Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
    Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced incorporation of exogenous arachidonic acid into phosphatidylinositol and other phospholipids during the early stages of thrombin-induced aggregation in gerbil platelets.
    Agwu DE; Johnstone I; Crane S; Holub BJ
    Lipids; 1983 Dec; 18(12):859-62. PubMed ID: 6420635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin, collagen and A23187 stimulated endogenous platelet arachidonate metabolism: differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor.
    Feinstein MB; Becker EL; Fraser C
    Prostaglandins; 1977; 14(6):1075-93. PubMed ID: 341226
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen.
    Takamura H; Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
    J Biol Chem; 1987 Feb; 262(5):2262-9. PubMed ID: 3102469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde.
    Davies JA; Menys VC
    Thromb Res; 1982 Apr; 26(1):31-41. PubMed ID: 7101245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    GrodziƄska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.